Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

NYSE:ALB - New York Stock Exchange, Inc. - US0126531013 - Common Stock - Currency: USD

59.32  +0.08 (+0.14%)

Premarket: 59.26 -0.06 (-0.1%)

Fundamental Rating

3

ALB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. ALB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALB had negative earnings in the past year.
In the past year ALB had a positive cash flow from operations.
Of the past 5 years ALB 4 years were profitable.
Each year in the past 5 years ALB had a positive operating cash flow.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

With a Return On Assets value of -7.69%, ALB is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -13.04%, ALB is doing worse than 75.29% of the companies in the same industry.
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

Looking at the Gross Margin, with a value of 3.53%, ALB is doing worse than 87.06% of the companies in the same industry.
In the last couple of years the Gross Margin of ALB has declined.
The Profit Margin and Operating Margin are not available for ALB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALB has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALB has more shares outstanding
The debt/assets ratio for ALB has been reduced compared to a year ago.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ALB has an Altman-Z score of 1.41. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALB (1.41) is worse than 67.06% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that ALB is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.31, ALB is doing good in the industry, outperforming 72.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACCN/A
WACC8.15%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

ALB has a Current Ratio of 2.11. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALB (2.11) is comparable to the rest of the industry.
ALB has a Quick Ratio of 1.26. This is a normal value and indicates that ALB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALB (1.26) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.26
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The earnings per share for ALB have decreased strongly by -122.82% in the last year.
The Revenue for ALB has decreased by -39.34% in the past year. This is quite bad
ALB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.42% yearly.
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%

3.2 Future

ALB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 65.34% yearly.
ALB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.72% yearly.
EPS Next Y37.37%
EPS Next 2Y55.59%
EPS Next 3Y58.33%
EPS Next 5Y65.34%
Revenue Next Year-11.33%
Revenue Next 2Y-1.06%
Revenue Next 3Y4.91%
Revenue Next 5Y13.72%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALB. In the last year negative earnings were reported.
ALB is valuated quite expensively with a Price/Forward Earnings ratio of 60.25.
Based on the Price/Forward Earnings ratio, ALB is valued a bit more expensive than the industry average as 71.76% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of ALB to the average of the S&P500 Index (22.43), we can say ALB is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 60.25
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALB is valued expensively inside the industry as 80.00% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 58.1
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

ALB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ALB's earnings are expected to grow with 58.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.59%
EPS Next 3Y58.33%

6

5. Dividend

5.1 Amount

ALB has a Yearly Dividend Yield of 2.69%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of ALB has falen by -26.95%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.70, ALB pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, ALB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

On average, the dividend of ALB grows each year by 13.04%, which is quite nice.
ALB has been paying a dividend for at least 10 years, so it has a reliable track record.
ALB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.04%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of ALB are negative and hence is the payout ratio. ALB will probably not be able to sustain this dividend level.
The dividend of ALB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-27.05%
EPS Next 2Y55.59%
EPS Next 3Y58.33%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ALBEMARLE CORP

NYSE:ALB (5/20/2025, 8:04:00 PM)

Premarket: 59.26 -0.06 (-0.1%)

59.32

+0.08 (+0.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners99.62%
Inst Owner Change-0.99%
Ins Owners0.22%
Ins Owner Change14.75%
Market Cap6.98B
Analysts69.09
Price Target83.98 (41.57%)
Short Float %14.56%
Short Ratio5.03
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend2.65
Dividend Growth(5Y)13.04%
DP-27.05%
Div Incr Years30
Div Non Decr Years30
Ex-Date06-13 2025-06-13 (0.405)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-54.53%
Max EPS beat(2)69.72%
EPS beat(4)1
Avg EPS beat(4)-81.09%
Min EPS beat(4)-249.28%
Max EPS beat(4)69.72%
EPS beat(8)3
Avg EPS beat(8)-26.81%
EPS beat(12)7
Avg EPS beat(12)-12.91%
EPS beat(16)11
Avg EPS beat(16)-4.32%
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-7.88%
Revenue beat(4)1
Avg Revenue beat(4)-3.24%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)5.88%
Revenue beat(8)3
Avg Revenue beat(8)-1.95%
Revenue beat(12)3
Avg Revenue beat(12)-2.81%
Revenue beat(16)5
Avg Revenue beat(16)-1.38%
PT rev (1m)-15.31%
PT rev (3m)-25.67%
EPS NQ rev (1m)-118.94%
EPS NQ rev (3m)-236.6%
EPS NY rev (1m)-9.19%
EPS NY rev (3m)-695.59%
Revenue NQ rev (1m)-2.06%
Revenue NQ rev (3m)-7.98%
Revenue NY rev (1m)-4.03%
Revenue NY rev (3m)-9.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 60.25
P/S 1.37
P/FCF N/A
P/OCF 6.07
P/B 0.7
P/tB 0.85
EV/EBITDA 58.1
EPS(TTM)-2.78
EYN/A
EPS(NY)0.98
Fwd EY1.66%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)9.77
OCFY16.47%
SpS43.3
BVpS85.24
TBVpS69.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.53%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 20.2
Cap/Depr 205.72%
Cap/Sales 25.31%
Interest Coverage N/A
Cash Conversion 742.04%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.26
Altman-Z 1.41
F-Score4
WACC8.15%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
EPS Next Y37.37%
EPS Next 2Y55.59%
EPS Next 3Y58.33%
EPS Next 5Y65.34%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%
Revenue Next Year-11.33%
Revenue Next 2Y-1.06%
Revenue Next 3Y4.91%
Revenue Next 5Y13.72%
EBIT growth 1Y40.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year160.58%
EBIT Next 3Y46.65%
EBIT Next 5Y39.51%
FCF growth 1Y-114.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.55%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%